Constipation - Functional, Functional Colonic Diseases, Hydrotherapy
Conditions
Keywords
constipation, internal hydrotherapy, Radiopaque Media, Functional Colonic Diseases
Brief summary
A randomised and controlled trial, in which the effect of Modern Colon Hydrotherapy is evaluated in the gastrointestinal transit of subjects with functional constipation
Detailed description
The aim of the present randomized randomised and controlled trial is to evaluate the effect of Modern Colon Hydrotherapy in the gastrointestinal transit of subjects with functional constipation. Two intervention groups were used, to which this type of treatment was applied and to which the intake of a product with prebiotic and prebiotic properties or a placebo was added, depending on the assigned group.
Interventions
OTHERModern Colon Hydrotherapy plus probiotic product intake
Colonic cleansing through 3 interventions of Modern Colon Hydrotherapy separated by 48 hours. In addition, a daily intake of a product with prebiotic and prebiotic properties for 30 days.
Sponsors
Universidad Complutense de Madrid
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Patients between 20 and 60 years of age with functional constipation of more than 5 years of evolution.
Exclusion criteria
* Taking any type of antibiotic in the last month * Taking prebiotics or probiotics products in the last month. * Taking laxatives in the last month. * Undergoing any medicinal treatment * Pregnancy * Subject with a history of current gastrointestinal pathology or disorder such as: acute colon pathology, acute haemorrhagic colitis, suspected digestive perforation, recent abdominal surgery, severe arterial hypertension, abdominal hernia, colon neoplasia, history of cardiac syncope, renal failure, liver cirrhosis, epilepsy, severe psychiatric illness (psychosis), necrosis due to abdominal irradiation, severe anaemia, severe neurovegetative lability.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| intestinal transit | 7 days | intestinal transit using radiopaque markers |
Countries
Spain
Contacts
Primary ContactIsidro Fernández-López, PhD.
Outcome results
None listed